研究者業績

菅原 斉

スガワラ ヒトシ  (Hitoshi Sugawara)

基本情報

所属
自治医科大学 医学部総合医学第1講座 教授
(兼任)総合診療科 教授
学位
医学博士(1994年3月 旭川医科大学)
FACP(1994年6月 American College of Physicians)

連絡先
hsmdfacpjichi.ac.jp
ORCID ID
 https://orcid.org/0000-0002-5060-9020
J-GLOBAL ID
200901030187469907
Researcher ID
Y-5081-2019
researchmap会員ID
1000273366

外部リンク

論文

 163
  • Ibuki Kurihara, Hajime Yamazaki, Sakura Kato, Noriko Oyama-Manabe, Hitoshi Sugawara
    BMC infectious diseases 24(1) 1437-1437 2024年12月18日  査読有り最終著者
    BACKGROUND: The spleen is a key organ in preventing pneumococcal infection, especially in patients with immunocompromised condition such as those with cancer. Previous studies have shown that a small spleen volume in pneumococcal pneumonia patients is associated with severe disease course. However, it is unknown whether a small spleen increases risk of pneumococcal infection. We investigated the association between spleen volume and risk of pneumococcal infection. METHODS: This study was a retrospective cohort study using a nested case-control design and involved adult patients with malignancy who underwent chest and/or abdominal CT scans from January 1, 2008, to September 30, 2020, at a tertiary care center in Japan. Exclusion criteria comprised patients diagnosed with hepatic cirrhosis, leukemia, lymphoma, and/or post-splenectomy. From the cohort group that met all selection criteria (n = 22475), we identified all incident cases of pneumococcal infection (pneumococcal pneumonia and/or invasive pneumococcal diseases) and matched them with four controls by age, sex, and follow-up duration. Odds ratios (ORs) for the association between spleen volume and pneumococcal infection were estimated using conditional logistic regression models adjusted for body surface area, performance status, Charlson comorbidity index, and metastatic cancer. RESULTS: The median spleen volume was 85.8 (interquartile range, 65.8-120.8) cm3. Over a median follow-up of 4.95 (interquartile range, 1.54-9.25) years, 60 patients were diagnosed with pneumococcal infection (20 with invasive pneumococcal disease and 40 with pneumonia without invasive pneumococcal disease) and matched with 240 controls. Spleen volume reduction (per 10 cm3) did not increase risk of pneumococcal infection in a crude analysis [OR 1.04 (95% CI 0.98-1.11)]. The outcome remained unchanged in the multivariable analysis (OR 1.01 [95% CI 0.95-1.08]). CONCLUSIONS: Small spleen volume did not increase risk of pneumococcal infection in cancer patients.
  • Michiko Matsuzawa Adachi, Katsuyuki Yoshida, Takeshi Yamashita, Takahiko Fukuchi, Hitoshi Sugawara
    Annals of Internal Medicine: Clinical Cases 3(8) 1-2 2024年8月1日  査読有り最終著者責任著者
  • Fukuko Matsumoto, Michiko Matsuzawa Adachi, Katsuyuki Yoshida, Takeshi Yamashita, Jun Shiihara, Takahiko Fukuchi, Haruka Morikawa, Masahiko Hiruta, Keisuke Tanno, Noriko Oyama-Manabe, Hisashi Oshiro, Hitoshi Sugawara
    Internal Medicine (3478-24) 1-14 2024年7月4日  査読有り責任著者
    We herein report a 47-year-old man who presented with progressive paraparesis. Imaging revealed a right upper pulmonary nodule, massive bilateral adrenal metastases, thoracolumbar vertebral osteolysis, and subcutaneous nodules. A biopsy of the right buttock nodule revealed a poorly differentiated metastatic carcinoma with high programmed cell death-ligand 1 expression and extensive chromosomal rearrangements. The patient died 10 days after the initiation of pembrolizumab treatment. Autopsy findings confirmed pulmonary pleomorphic carcinoma with extensive metastases. Quantification of chromosomal rearrangements revealed a jump-up mutation from the normal karyotype, followed by a further incremental increase in the degree of deviation.
  • Katsuyuki Yoshida, Soshi Takahashi, Ryota Kawai, Toshiharu Saito, Saori Hatachi, Ayumi Shintani, Hitoshi Sugawara, Shunichi Kumagai
    Rheumatology 2024年5月2日  査読有り
    Abstract Objective This study aimed to establish a screening model for differentiating anti-synthetase syndrome (ASS) from other antinuclear antibody (ANA)-associated rheumatic diseases (AARD) using a combination of cytoplasmic and non-cytoplasmic ANA (ncANA) patterns. Methods This retrospective observational study included patients with AARDs such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjögren's syndrome (SS), mixed connective tissue disease (MCTD), and polymyositis/dermatomyositis (PM/DM) who underwent ANA screening between April 2012 and December 2021. Variables included age, sex, ANA patterns (Cytoplasmic and ncANA), and titers. Logistic regression analysis of Cytoplasmic and ncANA patterns was performed to differentiate ASS from other AARDs. Result The 981 diagnosed cases of AARDs consisted of SS (n = 451), SSc (n = 264), SLE (n = 201), PM/DM (n = 104), MCTD (n = 52), and ASS, including PM/DM (n = 64). Of these, 155 patients had ≥2 overlapping diseases; however, there was no overlap between AARDs and ASS. ASS is more likely to occur when the cytoplasmic titer is positive and the ncANA <320. Receiver operating characteristic (ROC) analysis of the Cytoplasmic and ncANA range revealed an area under the ROC curve (AUC) of 0.885 (95% CI: 0.844 to 0.927). Conclusion It is important to detect cytoplasmic patterns as an ANA screening test for ASS diagnosis, even if the titer is low. Additionally, combining the cytoplasmic and ncANA patterns yields more accurate ASS screening results.
  • Hidenori Sanayama, Michito Namekawa, Yoshio Sakiyama, Hitoshi Sugawara
    Cureus Journal of Medical Science 16(3) e56698 2024年3月22日  査読有り最終著者
    Sanayama H, Namekawa M, Sakiyama Y, et al. (March 22, 2024) Herpes Zoster Ophthalmicus Initially Diagnosed As Cluster Headache, Complicated by Delayed Eruption. Cureus 16(3): e56698. doi:10.7759/cureus.56698
  • Takeshi Yamashita, Takahiko Fukuchi, Hitoshi Sugawara, Yoshiro Okajima, Masahiro Hiruta
    Cureus Journal of Medical Science 16(3) e55749 2024年3月7日  査読有り最終著者
  • Ibuki Kurihara, Hitoshi Sugawara
    PLOS ONE 19(2) e0290937-e0290937 2024年2月23日  査読有り最終著者
    Background The coronavirus disease 2019 (COVID-19) pandemic has put a strain on the healthcare system, and sudden changes in disease status during home treatment have become a serious issue. Therefore, prediction of disease severity and allocation of sufficient medical resources, including high-flow nasal cannula (HFNC), to patients in need are important. We aimed to determine risk factors for the need of HFNC use in COVID-19. Methods This was a single-center retrospective observational cohort study including all eligible hospitalized adult patients aged ≥18 years diagnosed with COVID-19 between April 14, 2020 and August 5, 2021 who were treated in the study hospital. The primary outcome is the need for HFNC. Nineteen potential predictive variables, including patient characteristics at hospital admission, were screened using least absolute shrinkage and selection operator and logistic regression to construct a predictive risk score. Accuracy of the risk score was determined using area under the receiver operating characteristic curve. Results The study cohort included 148 patients. The rate of the need for HFNC was 22.9%. Among the 19 potential variables, percutaneous oxygen saturation (SpO2) <92% (odds ratio [OR] 7.50, 95% confidence interval [CI] 2.806–20.82) and IL-6 (OR 1.021, 95% CI 1.010–1.033) were included in developing the risk score, which was termed interleukin (IL)-6-based COVID-19 severity (IBC-S) score. Conclusions The IBC-S score, an easy-to-use risk score based on parameters available at the time of hospital admission, predicted the need for HFNC in patients with COVID-19. The IBC-S score based on interleukin-6 and SpO2 might aid in determining patients who should be transported to a tertiary medical institution or an isolation facility.
  • Reina Suzuki, Yusuke Iizuka, Hitoshi Sugawara, Alan Kawarai Lefor
    Dialogues in Health 4(100172) 1-7 2024年2月3日  査読有り
  • Marino Hirata, Takahiko Fukuchi, Hitoshi Sugawara, Ibuki Kurihara, Keishiro Sueda, Akira Ishi, Maya Takazawa, Yasuhiro Yamaguchi, Hisashi Oshiro, Takuro Sakagami
    Clinical Infection in Practice 21 100333-100333 2024年1月  査読有り
  • Michiko Matsuzawa Adachi, Katsuyuki Yoshida, Takahiko Fukuchi, Akira Tanaka, Naoto Yamamoto, Hitoshi Sugawara
    Clinical Case Reports 11(6) e7477 2023年6月20日  査読有り責任著者
  • Yoko Matsumoto, Keisuke Tanno, Yuhei Nakamura, Kohei Hamamoto, Hanako Yoshihara, Takahiko Fukuchi, Noriko Oyama-Manabe, Hitoshi Sugawara
    Clinical case reports 11(6) e7576 2023年6月19日  査読有り責任著者
    KEY CLINICAL MESSAGE: With the aging of the population, physicians need to pay more attention to assessing the presence or absence of pelvic fractures and urinary retention associated with urethral injury due to such fractures in the elderly when falling from bicycles. ABSTRACT: Walking ability does not rule out the presence of pelvic fractures. Many geriatric patients are likely to fall off bicycles. Physicians should pay more attention when assessing complications related to urethral trauma caused by pelvic fractures in the elderly after falling from bicycles.
  • Hidenori Sanayama, Kiyonori Ito, Susumu Ookawara, Takeshi Uemura, Yoshio Sakiyama, Hitoshi Sugawara, Kaoru Tabei, Kazuei Igarashi, Kuniyasu Soda
    Biomedicines 11(5) 1403-1403 2023年5月9日  査読有り
    Early diagnosis and therapeutic intervention improve the quality of life and prognosis of patients with sarcopenia. The natural polyamines spermine and spermidine are involved in many physiological activities. Therefore, we investigated blood polyamine levels as a potential biomarker for sarcopenia. Subjects were Japanese patients >70 years of age who visited outpatient clinics or resided in nursing homes. Sarcopenia was determined based on muscle mass, muscle strength, and physical performance according to the criteria of the Asian Working Group for Sarcopenia (2019). The analysis included 182 patients (male: 38%, age: 83 [76–90] years). Spermidine levels were higher (p = 0.002) and the spermine/spermidine ratio was lower (p < 0.001) in the sarcopenia group than in the non-sarcopenia group. Polyamine concentration analysis showed that the odds ratios for age and spermidine changed in parallel with sarcopenia progression, and the odds ratio for the spermine/spermidine ratio changed inversely with the degree of sarcopenia progression. Additionally, when the odds ratio was analyzed with spermine/spermidine instead of polyamine concentrations, only for spermine/spermidine, the odds ratio values varied in parallel with the progression of sarcopenia. Based on the present data, we believe that the blood spermine/spermidine ratio may be a diagnostic indicator of risk for sarcopenia.
  • Michiko Matsuzawa Adachi, Hitoshi Sugawara, Akira Ishii, Emiko Chiba, Kohei Hamamoto, Toshio Demitsu, Shigeki Yamada
    Internal Medicine 2023年3月  査読有り
  • Hidenori Sanayama, Kiyonori Ito, Susumu Ookawara, Takeshi Uemura, Sojiro Imai, Satoshi Kiryu, Miho Iguchi, Yoshio Sakiyama, Hitoshi Sugawara, Yoshiyuki Morishita, Kaoru Tabei, Kazuei Igarashi, Kuniyasu Soda
    Biomedicines 11(3) 746-746 2023年3月1日  査読有り
    Several mechanisms strictly regulate polyamine concentration, and blood polyamines are excreted in urine. This indicates polyamine accumulation in renal dysfunction, and studies have shown increased blood polyamine concentrations in patients with renal failure. Hemodialysis (HD) may compensate for polyamine excretion; however, little is known about polyamine excretion. We measured whole-blood polyamine levels in patients on HD and examined the relationship between polyamine concentrations and indicators associated with health status. Study participants were 59 hemodialysis patients (median age: 70.0 years) at Minami-Uonuma City Hospital and 26 healthy volunteers (median age: 44.5 years). Whole-blood spermidine levels were higher and spermine/spermidine ratio (SPM/SPD) was lower in hemodialysis patients. Hemodialysis showed SPD efflux into the dialysate; however, blood polyamine levels were not altered by hemodialysis and appeared to be minimally excreted. The skeletal muscle mass index (SMI), which was positively correlated with hand grip strength and serum albumin level, was positively correlated with SPM/SPD. Given that sarcopenia and low serum albumin levels are reported risk factors for poor prognosis in HD patients, whole blood SPM/SPD in hemodialysis patients may be a new indicator of the prognosis and health status of HD patients.
  • Marino Hirata, Nozomu Yoshino, Maya Takazawa, Hisashi Oshiro, Shinichi Kako, Hitoshi Sugawara
    Annals of Internal Medicine: Clinical Cases 2(2) 2023年2月1日  査読有り最終著者
  • Takeshi Yamashita, Takahiko Fukuchi, Hitoshi Sugawara
    Journal of General and Family Medicine 2022年11月7日  査読有り最終著者
  • Tamami Watanabe, Hitoshi Sugawara, Takahiko Fukuchi, Kiyoka Omoto
    Medicine 101(43) e31300-e31300 2022年10月28日  査読有り責任著者
  • Ibuki Kurihara, Chihiro Terai, Hiroki Yabe, Hitoshi Sugawara
    American Journal of Case Reports 23 2022年10月3日  査読有り最終著者
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    European Journal of Internal Medicine 2022年7月5日  査読有り最終著者
  • Tamami Watanabe, Takeshi Yamashita, Hitoshi Sugawara
    Internal Medicine 61(10) 1629-1629 2022年5月15日  査読有り最終著者
  • Hitoshi Sugawara
    The Korean journal of internal medicine 2022年5月6日  査読有り最終著者
  • Marino Hirata, Takahiko Fukuchi, Hitoshi Sugawara
    International Journal of Infectious Diseases 118(May 2022) 138-140 2022年5月  査読有り最終著者
  • Hanako Yoshihara, Ibuki Kurihara, Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    Cureus Journal of Medical Science 14(4) e24573 2022年4月28日  査読有り最終著者
  • Kazuo Kitagawa, Hisatomi Arima, Yasumasa Yamamoto, Shinichiro Ueda, Hiromi Rakugi, Takahide Kohro, Koji Yonemoto, Masayasu Matsumoto, Takao Saruta, Kazuyuki Shimada, Kazuyuki Shimada, Kazuyuki Shimada, Kazuo Kitagawa, Yasumasa Yamamoto, Hisatomi Arima, Shinichiro Ueda, Takahide Kohro, Koji Yonemoto, Kazuyuki Shimada, Satoshi Umemura, Yasushi Okada, Genjiro Kimura, Kazuaki Shimamoto, Norio Tanahashi, Jitsuo Higaki, Masayasu Matsumoto, Masayasu Matsumoto, Sadayoshi Ito, Shinichiro Ueda, Yusuke Ohya, Kazuo Kitagawa, Yasumasa Yamamoto, Hiromi Rakugi, Kazuo Minematsu, Kazuomi Kario, Yoshihiko Saito, Yasuo Terayama, Kazunori Toyoda, Takafumi Okura, Haruhiko Hoshino, Hirofumi Makino, Kazuo Eguchi, Haruhito Uchida, Hisatomi Arima, Takahide Khoro, Koji Yonemoto, Shinichiro Uchiyama, Hideki Etani, Tatsuo Kohriyama, Hidekazu Tomimoto, Taku Yoshio, Takao Saruta, Shotai Kobayashi, Hiroko Usami, Satoshi Iihoshi, Takeshi Mikami, Nobuhiro Mikuni, Kei Miyata, Tomohiro Murakami, Hideki Endo, Takahito Fukui, Kentaro Fumoto, Keiji Hara, Kaori Honjo, Kenji Kamiyama, Yusuke Kinoshita, Masana Maeda, Masaaki Mikamoto, Daisuke Mori, Takeo Murahashi, Ryota Nomura, Shusaku Noro, Tatsuya Ogino, Masahiro Okuma, Yasuhumi Otake, Koichiro Shindo, Hironori Sugio, Hidekazu Takada, Kazuki Takahira, Akiko Takeuchi, Toshiichi Watanabe, Yohei Yamaguchi, Takeo Abumiya, Kiyohiro Houkin, Shigeki Matsumura, Tomohiro Murakami, Rikiya Shinohe, Kiyomi Kuroshima, Katsumi Takizawa, Kazuto Yoshida, Hideo Morimoto, Naoyuki Hasebe, Satoshi Koyama, Junichi Maruyama, Shinsuke Irie, Takahiro Nakano, Yukari Ogasawara, Hiroki Ohkuma, Kazuo Shibanai, Kentaro Hikichi, Shinya Kobayashi, Junta Moroi, Taizen Nakase, Takeshi Okada, Daiki Takano, Shunsuke Takenaka, Shotaro Yoshioka, Toshiharu Yanagisawa, Yutaka Hirata, Shu Konno, Tomohiko Sato, Miiko Ito, Rei Kondo, Wataru Mori, Shinjiro Saito, Yasuaki Kokubo, Hideaki Kato, Hideki Oyama, Kaneyuki Matsuo, Masahiro Matsumoto, Mari Nakamura, Takayuki Koizumi, Hiroyuki Sato, Yasushi Shibata, Kazuo Eguchi, Kazuomi Kario, Masaaki Hashimoto, Kazuo Eguchi, Hideharu Kurita, Eiji Matsumoto, Koji Ishiguro, Ken Asakura, Hiroya Fujimaki, Kazuki Wakabayashi, Kazunori Akaji, Tomo Horikoshi, Tadashige Kano, Takao Kanzawa, Takehiro Katano, Hiroaki Kimura, Ban Mihara, Kentaro Suzuki, Yohei Takayama, Akira Ishii, Sin-ichi Momomura, Hitoshi Sugawara, Takeshi Yamashita, Uichi Kaneko, Toshie Takahashi, Toshinari Arai, Yoshihiro Tanaka, Shigehisa Inokuma, Yuji Kato, Norio Tanahashi, Naoki Ishige, kazuhiro Muramatsu, Shigeru Nogawa, Takahito Yoshizaki, Takashi Ohashi, Sumio Suda, Tokyo, Yasuyuki Iguchi, Hidetaka Mitsumura, Tomohide Adachi, Haruhiko Hoshino, Fumie Konoeda, Koichi Oki, Ryota Tanaka, Takao Urabe, Kazuo Yamashiro, Akihiro Ito, Hirofumi Nakatomi, Masaaki Shojima, Kuniaki Otsuka, Koichi Shibata, Takato Abe, Yoshiaki Itoh, Koichi Oki, Norihiro Suzuki, Kazuo Kitagawa, Sono Toi, Tamio Teramoto, Atsushi Fukunaga, Yuki Kujuro, Kouichi Ohta, Takashi Osada, Katuyoshi Shimizu, Yasuhisa Kitagawa, Kentaro Tokuoka, Masao Omura, Hideyuki Kikyo, Tomoya Kamide, Yoshihisa Kitamura, Katsuyoshi Miyashita, Kentaro Mori, Hiroshi Shima, Akira Tamase, Tsugio Akutsu, Kazutoshi Nishiyama, Shunya Takizawa, Tsuyoshi Uesugi, Uichi Ikeda, Megumi Koshikawa, Saeko Yamasaki, Atsushi Inoue, Yasuko Matsumoto, Kazuyoshi Yamaguchi, Genjirou Hirose, Satoshi Kontani, Kazuya Takasawa, Katsumi Hirahara, Makoto Kodama, Nobue Yagihara, Takashi Hata, Makoto Hori, Rokuhei Oda, Ayuka Kubo, Satoshi Okuda, Kentaro Yamada, Hiroki Takeuchi, Yoshio Araki, Mizuki Ito, Joe Senda, Toshihiko Wakabayashi, Shinji Ito, Tatsuro Mutoh, Yukinori Kawase, Fumio Ando, Shinya Okamoto, Takuya Shimada, Akihiro Shindo, Masakatsu Nishikawa, Atsushi Niwa, Ryogen Sasaki, Akihiro Shindo, Hidekazu Tomimoto, Hiroto Murata, Kenichiro Yata, Koushun Matsuo, Hideo Yagi, Toshiyuki Shiogai, Yoshinari Nagakane, Yasumasa Yamamoto, Jun Fujinami, Masanori Nakagawa, Ryo Ohara, Yasuhiro Tomii, Yoshiki Arakawa, Takeshi Funaki, Masafumi Ihara, Akihiro Kitamura, Takakuni Maki, Susumu Miyamoto, Yoshifumi Nakaya, Ryosuke Takahashi, Yohei Takenobu, Kazumichi Yoshida, Tadashi Ino, Nagako Murase, Ryo Ohotani, Yasuhiro Tomii, Yasumasa Yamamoto, Atsushi Kawashima, Akiko Watanabe, Yuko Hayashi, Takuma Ohmichi, Rei Yasuda, Akira Yoshioka, Natsuko Yuki, Masahiro Makino, Yasuhiro Tomii, Tatsuyuki Yamaguchi, Jyo Matsuzaki, Hitoshi Niki, Shoichi Shiraishi, Takehiko Yanagihara, Keiichi Yamada, Jun Hatate, Kaori Miwa, Shuhei Okazaki, Shoji Arihiro, Ryosuke Doijiri, Kyoko Higashida, Katsufumi Kajimoto, Kotaro Miyashita, Kazuyuki Nagatsuka, Kozue Saito, Yuri Sugiura, Hotake Takizawa, Takako Torii, Kazunori Toyoda, Chiaki Yokota, Yoshinaga Kajimoto, Toshihiko Kuroiwa, Ryuzo Fukunaga, Tsutomu Takahashi, Kazutami Nakao, Yuta Kajiyama, Yasuyoshi Kimura, Takashi Naka, Hironori Otomune, Takao Tanahashi, Takuya Uehara, Hiroyuki Hashimoto, Toshihiko Uematsu, Kazuo Kataoka, Satoshi Okayama, Satoshi Somekawa, Shuichi Yamada, Rie Sasaki, Shigeru Yamano, Naoyuki Nakao, Shinji Obayashi, Hirotoshi Hamaguchi, Tatsushi Toda, Kazuo Washida, Taku Hoshi, Tomoyuki Kono, Hiroaki Sekiya, Norifumi Sugo, Kenichi Todo, Masaya Togo, Hiroshi Yamagami, Shiro Yamamoto, Yoshihiko Shiro, Norifumi Sugo, Hirotoshi Hamaguchi, Toshio Takaoka, Satoshi Abe, Chizuko Hamada, Masaki Ishihara, Katuhiko Kadota, Tomonori Nakagawa, Hiroaki Oguro, Hiroyuki Takayoshi, Takuya Yamaguchi, Shuuhei Yamaguchi, Ryo Mizuhara, Kazunori Okada, Shingo Yamagata, Kazunori Okada, Akira Sasaki, Koji Abe, Kentaro Deguchi, Shoko Deguchi, Yumiko Nakano, Satoshi Hirai, Masaaki Uno, Kimihiko Yokosuka, Yasuhiro Manabe, Hijiri Ito, Shiro Aoki, Naohisa Hosomi, Yasuki Kihara, Tomohiko Kisaka, Hirofumi Maruyama, Masayasu Matsumoto, Hayato Araki, Ryo Ogami, Tsuyoshi Torii, Noboru Yokoyama, Takakazu Yokoyama, Satoshi Kataoka, Takeshi Kitamura, Takashi Kanda, Toshihiko Maeda, Fumitaka Shimizu, Kozaburo Seki, Yuko Bando, Masaki Ohara, Masahiro Yamasaki, Noritaka Masahira, Tetsuya Ueba, Yusuke Ueba, Norio Sunami, Yuichi Fujimoto, Keiko Haro, Hidenori Ogata, Norihiko Shida, Takeshi Matsumoto, Kensho Okamoto, Jitsuo Higaki, Takafumi Okura, Ryuichi Kawamoto, Shuji Arakawa, Shoji Arihiro, Hirofumi Shii, Hidetoshi kanai, Shigeru Fujimoto, Juro Jinnouchi, Takayuki Matsuki, Masato Osaki, Kimika Arakawa, Ai Ibaraki, Kanako Kiyohara, Yuko Ohta, Hideyuki Oniki, Minako Sakaki, Mitsuhiro Tominaga, Takuya Tsuchihashi, Saho Higashi, Hiromi Ishikawa, Koji Ishitsuka, Jiro Kitayama, Hiroshi Nakane, Takeo Yoshimura, Shunsuke Kakino, Yoshirou Kaneko, Junnosuke Inoue, Yoshikazu Maruyama, Katsunori Isa, Yusuke Ohya, Hirokuni Sakima, Seigo Nakada
    Hypertension Research 45(4) 591-601 2022年4月  
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    Cureus Journal of Medical Science 14(3) e23498 2022年3月25日  査読有り最終著者
  • Ibuki Kurihara, Keiji Hirai, Susumu Ookawara, Akira Tanaka, Tsuneaki Kenzaka, Hitoshi Sugawara
    American Journal of Case Reports 23 2022年2月2日  査読有り最終著者
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    Oxford Medical Case Reports 2022(2) 2022年2月1日  査読有り最終著者
  • Hiroshi Hori, Hitoshi Sugawara
    Cureus 14(1) e21622 2022年1月26日  査読有り最終著者
  • Takahiko Fukuchi, Hitoshi Sugawara
    Internal medicine (Tokyo, Japan) 60(22) 3659-3659 2021年11月15日  査読有り最終著者
  • Ai Kawamura, Hitoshi Sugawara, Takahiko Fukuchi, Akira Tanaka
    Cureus 13(10) e18967 2021年10月22日  査読有り
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    European journal of internal medicine 2021年10月21日  最終著者
  • Hiroshi Hori, Takahiko Fukuchi, Masamitsu Sanui, Takashi Moriya, Hitoshi Sugawara
    PLOS ONE 16(10) e0257513-e0257513 2021年10月11日  査読有り最終著者
    <sec id="sec001"> <title>Background</title> Coronavirus disease (COVID-19) is associated with a high mortality rate in older adults; therefore, it is important for medical institutions to take measures to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. This study aimed to assess the risk of SARS-CoV-2 infection among healthcare workers (HCWs) and the effectiveness of infection control measures. </sec> <sec id="sec002"> <title>Methods</title> This study had a cross-sectional component and a prospective cohort component. The cross-sectional component comprised an anti-SARS-CoV-2 antibody survey among HCWs at a medical center in Saitama City, Japan. In the prospective cohort component, HCWs at the same medical center were tested for anti-SARS-CoV-2 antibodies monthly over a 3-month period (May to July 2020) to assess the effectiveness of infection prevention measures, including personal protective equipment use. All participants in the cohort study also participated in the antibody survey. The primary outcome was anti-SARS-CoV-2 antibody (measured using Elecsys® Anti-SARS-CoV-2) positivity based on whether participants were engaged in COVID-19-related medical care. Other risk factors considered included occupational category, age, and sex. </sec> <sec id="sec003"> <title>Results</title> In total, 607 HCWs participated in the antibody survey and 116 doctors and nurses participated in the cohort study. Only one of the 607 participants in the survey tested positive for anti-SARS-CoV-2 antibodies. All participants in the cohort study were anti-SARS-CoV-2 antibody negative at baseline and remained antibody negative. Engaging in the care of COVID-19 patients did not increase the risk of antibody positivity. During the study period, a total of 30 COVID-19 in-patients were treated in the hospital. </sec> <sec id="sec004"> <title>Conclusions</title> The infection control measures in the hospital protected HCWs from nosocomially acquired SARS-CoV-2 infection; thus, HCWs should engage in COVID-19-related medical care with confidence provided that they adhere to infectious disease precautions. </sec>
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    Journal of general internal medicine 36(10) 3224-3225 2021年10月  査読有り最終著者
  • Ibuki Kurihara, Takahiko Fukuchi, Hanako Yoshihara, Kenichi Sakakura, Hitoshi Sugawara
    Journal of General and Family Medicine 2021年8月22日  査読有り最終著者
  • Ibuki Kurihara, Katsuyuki Yoshida, Takahiko Fukuchi, Hitoshi Sugawara
    Clinical case reports 9(7) e04476 2021年7月  査読有り最終著者
    In the era of a severely aging population, physicians should pay attention to look for both infective endocarditis and disseminated lesions when blood cultures reveal Staphylococcus warneri, especially in elderly people with valvular heart disease.
  • Yuki Kubota, Hiroshi Hori, Hitoshi Sugawara
    Internal medicine (Tokyo, Japan) 2021年3月29日  査読有り最終著者
  • Kai Saito, Hitoshi Sugawara, Kiyoshi Ichihara, Tamami Watanabe, Akira Ishii, Takahiko Fukuchi
    PLOS ONE 16(2) e0246259-e0246259 2021年2月19日  査読有り責任著者
    The risk factors associated with mortality in patients with extremely high serum C-reactive protein (CRP) levels are controversial. In this retrospective single-center cross-sectional study, the clinical and laboratory data of patients with CRP levels ≥40 mg/dL treated in Saitama Medical Center, Japan from 2004 to 2017 were retrieved from medical records. The primary outcome was defined as 72-hour mortality after the final CRP test. Forty-four mortal cases were identified from the 275 enrolled cases. Multivariate logistic regression analysis (MLRA) was performed to explore the parameters relevant for predicting mortality. As an alternative method of prediction, we devised a novel risk predictor, “weighted average of risk scores” (WARS). WARS features the following: (1) selection of candidate risk variables for 72-hour mortality by univariate analyses, (2) determination of C-statistics and cutoff value for each variable in predicting mortality, (3) 0–1 scoring of each risk variable at the cutoff value, and (4) calculation of WARS by weighted addition of the scores with weights assigned according to the C-statistic of each variable. MLRA revealed four risk variables associated with 72-hour mortality—age, albumin, inorganic phosphate, and cardiovascular disease—with a predictability of 0.829 in C-statistics. However, validation by repeated resampling of the 275 records showed that a set of predictive variables selected by MLRA fluctuated occasionally because of the presence of closely associated risk variables and missing data regarding some variables. WARS attained a comparable level of predictability (0.837) by combining the scores for 10 risk variables, including age, albumin, electrolytes, urea, lactate dehydrogenase, and fibrinogen. Several mutually related risk variables are relevant in predicting 72-hour mortality in patients with extremely high CRP levels. Compared to conventional MLRA, WARS exhibited a favorable performance with flexible coverage of many risk variables while allowing for missing data.
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    Internal Medicine 60(4) 495-506 2021年2月15日  査読有り最終著者
    The prevalence of atrial fibrillation (AF) increases with age, as does the proportion of patients with frailty. AF patients with frailty have a higher risk of stroke than those without frailty, and progressive frailty caused by stroke is also associated with a worse prognosis. Despite this, anticoagulant therapy tends to not be used in frail patients because of the risk of falls and bleeding complications. However, some studies have shown that anticoagulant therapy improves the prognosis in patients with frailty. An accurate assessment of the “netclinical-benefits” is needed in patients with frailty, with the aim of improving the prognoses of patients with frailty by selecting those who will benefit from anticoagulant therapy and actively reducing the risk of bleeding. A comprehensive intervention that includes a team of doctors and social resources is required. We herein review the effectiveness and bleeding risk associated with anticoagulant therapy in frail patients investigated in clinical studies.
  • Tamami Watanabe, Hitoshi Sugawara, Kai Saito, Akira Ishii, Takahiko Fukuchi, Kiyoka Omoto
    Medicine 100(4) e24510-e24510 2021年1月29日  査読有り責任著者
    The risk factors associated with 72-hours mortality in patients with extremely high levels of random plasma glucose (RPG) remain unclear. To explore the risk factors predictive of 72-hours mortality in patients with extremely high RPG under heterogenos pathophysiological conditions. Retrospective, single-center, case-controlled cross-sectional study. University teaching hospital. Adults over age 18 were selected from the medical records of patients at the Saitama Medical Center, Japan, from 2004 to 2013. Extremely high RPG (≥500 mg/dl). Mortality at 72 hours following the RPG test, regardless of hospitalization or in an outpatient setting. Multivariate logistic regression analysis was performed with adjustment for age, sex, body mass index (BMI), and RPG level. The final prediction model was built using the logistic regression model with a higher C-statistic, specificity, and sensitivity. A total of 351 patients with RPG ≥500 mg/dl were identified within the 10-year period. The 72-hours mortality rate was 16/351 (4.6%). The C-statistics of the 72-hours mortality prediction model with serum albumin (ALB) and creatine kinase (CK) was 0.856. The probability of 72-hours mortality was calculated as follows: 1/[1 + exp (−5.142 + 0.901log (CK) −1.087 (ALB) + 0.293 (presence (1) or absence (0) of metastatic solid tumor)]. The sensitivity and specificity of this model was 75.5%. The independent risk factors associated with 72-hours mortality in patients with RPG ≥500 mg/dl are hypoalbuminemia, elevated CK, and presence of a metastatic solid tumour. Further research is needed to understand the mechanisms and possible interventions to prevent mortality associated with extremely high RPG.
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    Journal of General and Family Medicine 22(1) 51-52 2021年1月13日  査読有り最終著者
    A 72‐year‐old woman presented with a 1‐day history of acute throat pain, hoarseness. On cervical ultrasonography (transverse view), the epiglottis was swollen with anterior‐posterior diameter of 3.5 and 3.8 mm at right and left edges, respectively. Laryngeal endoscopy showed marked swelling of the epiglottis, and acute epiglottitis was diagnosed.
  • Kai Saito, Hitoshi Sugawara, Tamami Watanabe, Akira Ishii, Takahiko Fukuchi
    Scientific Reports 11(1) 1-10 2021年1月12日  査読有り責任著者
    <title>Abstract</title>Risk factors associated with 72-h mortality in patients with extremely high serum aspartate aminotransferase levels (AST; ≥ 3000 U/L) are unknown. This single-centre, retrospective, case-controlled, cross-sectional study obtained data from medical records of adult patients treated at Saitama Medical Center, Japan, from 2005 to 2019. We conducted a multivariate logistic after adjusting for age, sex, height, weight, body mass index, Brinkman Index, vital signs, biochemical values, updated Charlson Comorbidity Index (CCI) score, CCI components, and underlying causes. A logistic regression model with selected validity risks and higher C-statistic for predicting 72-h mortality was established. During the 15-year period, 428 patients (133 non-survivors and 295 survivors [cases and controls by survival &lt; 72 and ≥ 72 h, respectively]) with AST levels ≥ 3000 U/L were identified. The 72-h mortality rate was 133/428 (31.1%). The model used for predicting 72-h mortality through the assessment of alkaline phosphatase, creatine kinase, serum sodium, potassium, and phosphorus levels had a C-statistic value of 0.852 (sensitivity and specificity, 76.6%). The main independent risk factors associated with 72-h mortality among patients with AST levels ≥ 3000 U/L included higher serum values of alkaline phosphatase, creatine kinase, serum sodium, potassium, and phosphorus.
  • Hiroshi Hori, Hiroki Yabe, Takahiko Fukuchi, Hitoshi Sugawara
    Clinical Case Reports 9(1) 153-157 2021年1月5日  査読有り最終著者
    Adult‐onset Still's disease may cause intestinal pseudo‐obstruction via a cytokine storm. Early diagnosis and treatment are the key for patient survival before the development of serious complications such as macrophage activation syndrome.
  • Hiroshi Hori, Yusuke Ozeki, Tsuyoshi Kobashigawa, Kazusige Futsuhara, Akira Tanaka, Eri Watanabe, Hiroki Yabe, Toru Yago, Takahiko Fukuchi, Hitoshi Sugawara, Shigeru Kotake
    Modern Rheumatology Case Reports 5(1) 62-68 2021年1月2日  査読有り最終著者
    A 71-year-old woman with dermatomyositis (DM) received glucocorticoid steroid (GCS) and tacrolimus treatment. Relapse of skin symptoms was observed after tapering the GCS dose, and the patient tested positive for anti-transcriptional intermediary factor-1 gamma (TIF1-γ) antibody. Examinations for malignancy were repeatedly performed. However, no obvious findings indicative of a tumour were observed. Two years after, a retroperitoneal tumour was detected and pathologically diagnosed as poorly differentiated adenocarcinoma. The patient developed intestinal and biliary obstruction and eventually died of sepsis. Herein, we report the presence of anti-TIF1-γ antibodies in a DM patient with cancer of unknown primary site.
  • Jumpei Taniguchi, Hitoshi Sugawara, Hodaka Yamada, Katsuyuki Yoshida, Ibuki Kurihara, Masashi Yoshida, Akira Ishii, Takahiko Fukuchi, Wilfred Y. Fujimoto
    Clinical Case Reports 8(12) 3082-3087 2020年12月18日  査読有り責任著者
    Physicians must recognize and treat adrenal crisis that may occur with acute viral illnesses such as influenza in women with Sheehan’s syndrome that has been undiagnosed and hence untreated, sometimes for many years, after postpartum hemorrhage.
  • Naoko Yukihira, Hiroshi Hori, Takeshi Yamashita, Ai Kawamura, Takahiko Fukuchi, Hitoshi Sugawara
    Internal medicine (Tokyo, Japan) 60(10) 1621-1625 2020年12月15日  査読有り最終著者
    Aggregatibacter actinomycetemcomitans, an etiological agent associated with periodontitis, endocarditis, and other infections, has rarely been implicated in spondylitis. A 70-year-old man with aortic valve replacement presented with a 4-month history of lower back pain and was diagnosed with spondylitis. Prolonged incubation of blood cultures and a biopsy yielded A. actinomycetemcomitans. Concurrent infective endocarditis (IE) was probable considering the infectious organism and the patients' prosthetic valve. The patient was treated with ceftriaxone and recovered well. Pyogenic spondylitis with possible concurrent IE may be caused by A. actinomycetemcomitans. Extended incubation and repeated cultures should be considered if HACEK infection is suspected.
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    Journal of General and Family Medicine 21(6) 272-273 2020年11月28日  査読有り最終著者
    A 27-year-old woman complaining of persistent fever and sore throat was consulted. Examination of the laryngopharynx revealed multiple aphthous ulcers in the uvula, arytenoids, epiglottis, and laryngeal pyriform fossa. Crohn's disease was diagnosed by colonoscopy.
  • Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    European Journal of Internal Medicine 83 84-85 2020年11月15日  査読有り最終著者
    A 67-year-old man presented with a 15-year history of chronic urticaria. It was distributed symmetrically on the limb trunk (Fig. 1A and B) without pruritus. No fever or joint pain or headache is observed. He showed no signs of angioedema. He was referred to our hospital for treatment of chronic urticaria. An antihistamine was ineffective. He was diagnosed with mild sensorineural hearing loss. He had no family history of autoinflammatory diseases.
  • Mizuki Mogi, Hiroshi Hori, Takahiko Fukuchi, Hitoshi Sugawara
    Journal of General and Family Medicine 21(6) 277-279 2020年11月  査読有り最終著者
    We present a case of diffuse aspiration bronchiolitis (DAB) with a false‐positive Gaffky score. “Tree‐in‐bud” opacities detected after aspiration should be considered DAB rather than mycobacterial infection.
  • Takahiko Fukuchi, Hitoshi Sugawara
    Internal medicine (Tokyo, Japan) 60(5) 821-821 2020年9月30日  査読有り最終著者

主要な講演・口頭発表等

 106

共同研究・競争的資金等の研究課題

 6